![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KS Arts, JM Fujimoto and LF Tseng
Research Service, C. J. Zablocki Veterans Administration Medical Center, Milwaukee, Wisconsin.
In previous publications we proposed that dynorphin A (1-17) (Dyn) functions as an antianalgesic agent in the spinal cord of mice. Whether endogenously released or administered directly to the spinal cord, this antianalgesic action attenuates the antinociceptive effect of morphine (Mor) in the mouse tail-flick test. Because this action of Dyn in the spinal cord appeared to be congruous with the function of substance P (SP), experiments were designed to compare the actions of the two on Mor-induced antinociception. Inhibition of the tail-flick response induced by i.c.v. administration of Mor was attenuated by intrathecal (i.t.) administration of SP or Dyn. This antianalgesic effect of Dyn (5 fmol) but not SP (74 pmol) was antagonized by naloxone and nor- binaltorphimine administered i.t. Capsaicin (Cap) i.t. at a 0.1- microgram dose, like SP and Dyn, antagonized the antinociceptive effect of Mor given i.c.v. Excellent evidence exists to indicate that, in rats, Cap (30-70 micrograms i.t.) releases SP in the spinal cord and that Mor inhibits this release. Present experiments indicated, however, that i.t. administration of low doses of Cap (0.05-0.5 microgram) in mice preferentially released Dyn and not SP as based on the following results. 1) The antianalgesic action of Cap i.t. against Mor i.c.v. was antagonized by naloxone and nor-binaltorphimine i.t. as was Dyn i.t. (but not SP i.t.). 2) A SP antagonist, (D-Pro2, D-Phe7, D-Trp9)-SP, did not reverse the effect of Cap or Dyn given i.t., even though it antagonized the effect of SP.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. Terashvili, L. F. Tseng, H.-e. Wu, J. Narayanan, L. M. Hart, J. R. Falck, P. F. Pratt, and D. R. Harder Antinociception Produced by 14,15-Epoxyeicosatrienoic Acid Is Mediated by the Activation of {beta}-Endorphin and Met-Enkephalin in the Rat Ventrolateral Periaqueductal Gray J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 614 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Terashvili, H.-e. Wu, R. J. Leitermann, H.-S. Sun, A. D. Clithero, and L. F. Tseng Differential Mechanisms of Antianalgesia Induced by Endomorphin-1 and Endomorphin-2 in the Ventral Periaqueductal Gray of the Rat J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1257 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-E. Wu, H.-S. Sun, M. Darpolar, R. J. Leitermann, J. P. Kampine, and L. F. Tseng Dynorphinergic Mechanism Mediating Endomorphin-2-Induced Antianalgesia in the Mouse Spinal Cord J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1135 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Laughlin, A. A. Larson, and G. L. Wilcox Mechanisms of Induction of Persistent Nociception by Dynorphin J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 6 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Rady, W. B. Campbell, and J. M. Fujimoto Antianalgesic Action of Nociceptin Originating in the Brain Is Mediated by Spinal Prostaglandin E2 in Mice J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 7 - 14. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
